<DOC>
	<DOCNO>NCT02856698</DOCNO>
	<brief_summary>Acute pulmonary edema ( APE ) common condition emergency room , associate considerable mortality . The use intravenous morphine treatment APE remain controversial Benzodiazepines suggest alternative morphine relieve dyspnoea anxiety patient APE . The MIdazolan versus MOrphine APE trial ( MIMO ) multicenter , prospective , open-label , randomize study design evaluate efficacy safety morphine patient APE .</brief_summary>
	<brief_title>MIdazolam Versus MOrphine Acute Pulmonary Edema ( MIMO Trial )</brief_title>
	<detailed_description />
	<mesh_term>Edema</mesh_term>
	<mesh_term>Pulmonary Edema</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Patients acute pulmonary edema dyspnoea anxiety Patients know severe liver disease . Patients know severe renal disease . Patients expectation death illness course trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Acute heart failure</keyword>
	<keyword>morphine</keyword>
	<keyword>midazolam</keyword>
	<keyword>in-hospital mortality</keyword>
</DOC>